{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:52:02Z","timestamp":1773309122266,"version":"3.50.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,31]],"date-time":"2007-01-31T00:00:00Z","timestamp":1170201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2007,4,4]]},"DOI":"10.1007\/s11102-007-0001-6","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T20:04:16Z","timestamp":1170446656000},"page":"1-15","source":"Crossref","is-referenced-by-count":12,"title":["Anterior pituitary hormone replacement therapy\u2014a clinical review"],"prefix":"10.1007","volume":"10","author":[{"given":"Christoph J.","family":"Auernhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vlotides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,31]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","volume":"55","author":"M Regal","year":"2001","unstructured":"Regal M, Paramo C, Sierra SM, Garcia-Mayor RV (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:735\u2013740","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.01895","volume":"152","author":"M Bondanelli","year":"2005","unstructured":"Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, degli Uberti EC (2005) Hypopituitarism after traumatic brain injury. Eur J Endocrinol 152:679\u2013691","journal-title":"Eur J Endocrinol"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF03345336","volume":"28","author":"G Aimaretti","year":"2005","unstructured":"Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C et al (2005) Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest 28:984\u2013989","journal-title":"J Endocrinol Invest"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/02699050400025315","volume":"19","author":"E Ghigo","year":"2005","unstructured":"Ghigo E, Masel B, Aimaretti G, Leon-Carrion J, Casanueva FF, Dominguez-Morales MR et al (2005) Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj 19:711\u2013724","journal-title":"Brain Inj"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/eje.1.02071","volume":"154","author":"HJ Schneider","year":"2006","unstructured":"Schneider HJ, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B et al (2006) Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 154:259\u2013265","journal-title":"Eur J Endocrinol"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/neu.2005.22.937","volume":"22","author":"M Schneider","year":"2005","unstructured":"Schneider M, Schneider HJ, Stalla GK (2005) Anterior pituitary hormone abnormalities following traumatic brain injury. J Neurotrauma 22:937\u2013946","journal-title":"J Neurotrauma"},{"key":"1_CR7","first-page":"435","volume":"63","author":"E Endert","year":"2005","unstructured":"Endert E, Ouwehand A, Fliers E, Prummel MF, Wiersinga WM (2005) Establishment of reference values for endocrine tests. Part IV: adrenal insufficiency. Neth J Med 63:435\u2013443","journal-title":"Neth J Med"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","volume":"361","author":"W Arlt","year":"2003","unstructured":"Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881\u20131893","journal-title":"Lancet"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1210\/jc.2002-021897","volume":"88","author":"IL Schmidt","year":"2003","unstructured":"Schmidt IL, Lahner H, Mann K, Petersenn S (2003) Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic\u2013pituitary\u2013adrenal disease. J Clin Endocrinol Metab 88:4193\u20134198","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-006-6039-z","volume":"8","author":"MO Aken van","year":"2005","unstructured":"van Aken MO, Lamberts SW (2005) Diagnosis and treatment of hypopituitarism: an update. Pituitary 8:183\u2013191","journal-title":"Pituitary"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2265.1999.00679.x","volume":"50","author":"RP Dullaart","year":"1999","unstructured":"Dullaart RP, Pasterkamp SH, Beentjes JA, Sluiter WJ (1999) Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test. Clin Endocrinol (Oxf) 50:465\u2013471","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2005-1131","volume":"91","author":"A Agha","year":"2006","unstructured":"Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM (2006) The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic\u2013pituitary\u2013adrenal axis. J Clin Endocrinol Metab 91:43\u201347","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2265.2005.02421.x","volume":"64","author":"RM Reynolds","year":"2006","unstructured":"Reynolds RM, Stewart PM, Seckl JR, Padfield PL (2006) Assessing the HPA axis in patients with pituitary disease: a UK survey. Clin Endocrinol (Oxf) 64:82\u201385","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00017","volume":"139","author":"RI Dorin","year":"2003","unstructured":"Dorin RI, Qualls CR, Crapo LM (2003) Diagnosis of adrenal insufficiency. Ann Intern Med 139:194\u2013204","journal-title":"Ann Intern Med"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2002-020969","volume":"88","author":"HK Gleeson","year":"2003","unstructured":"Gleeson HK, Walker BR, Seckl JR, Padfield PL (2003) Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab 88:2106\u20132111","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.2005.02368.x","volume":"63","author":"M Klose","year":"2005","unstructured":"Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U (2005) Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf) 63:499\u2013505","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1210\/jc.2005-0354","volume":"90","author":"IE Widmer","year":"2005","unstructured":"Widmer IE, Puder JJ, Konig C, Pargger H, Zerkowski HR, Girard J et al (2005) Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 90:4579\u20134586","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.01911","volume":"152","author":"M Maghnie","year":"2005","unstructured":"Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C et al (2005) Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic\u2013pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol 152:735\u2013741","journal-title":"Eur J Endocrinol"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(98)85043-5","volume":"352","author":"SW Lamberts","year":"1998","unstructured":"Lamberts SW, de Herder WW, van der Lely AJ (1998) Pituitary insufficiency. Lancet 352:127\u2013134","journal-title":"Lancet"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2265.1997.780907.x","volume":"46","author":"SR Peacey","year":"1997","unstructured":"Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R et al (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 46:255\u2013261","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","volume":"46","author":"TA Howlett","year":"1997","unstructured":"Howlett TA (1997) An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 46:263\u2013268","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1365-2265.1999.00787.x","volume":"50","author":"SR Peacey","year":"1999","unstructured":"Peacey SR, Yuan Guo C, Eastell R, Weetman AP (1999) Optimization of glucocorticoid replacement therapy: the long-term effect on bone mineral density. Clin Endocrinol (Oxf) 50:815\u2013817","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR23","first-page":"179","volume":"61","author":"F Heureux","year":"2000","unstructured":"Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J (2000) Evaluation of corticosteroid replacement therapy and its effect on bones in Addison\u2019s disease. Ann Endocrinol (Paris) 61:179\u2013183","journal-title":"Ann Endocrinol (Paris)"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.1995.tb02602.x","volume":"42","author":"KA al-Shoumer","year":"1995","unstructured":"al-Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG (1995) Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clin Endocrinol (Oxf) 42:85\u201390","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-2265.2001.01269.x","volume":"54","author":"EM McConnell","year":"2001","unstructured":"McConnell EM, Bell PM, Hadden DR, McCance DR, Sheridan B, Atkinson AB (2001) Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 54:593\u2013599","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.0300-0664.2001.01447.x","volume":"56","author":"EM McConnell","year":"2002","unstructured":"McConnell EM, Bell PM, Ennis C, Hadden DR, McCance DR, Sheridan B et al (2002) Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clin Endocrinol (Oxf) 56:195\u2013201","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/07853890109002097","volume":"33","author":"TA Elhadd","year":"2001","unstructured":"Elhadd TA, Abdu TA, Clayton R (2001) Hypopituitarism and atherosclerosis. Ann Med 33:477\u2013485","journal-title":"Ann Med"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","volume":"31","author":"H Derendorf","year":"1991","unstructured":"Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M (1991) Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 31:473\u2013476","journal-title":"J Clin Pharmacol"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","volume":"169","author":"E Charmandari","year":"2001","unstructured":"Charmandari E, Johnston A, Brook CG, Hindmarsh PC (2001) Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 169:65\u201370","journal-title":"J Endocrinol"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jc.2003-030440","volume":"89","author":"JQ Purnell","year":"2004","unstructured":"Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH (2004) Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 89:281\u2013287","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0960-0760(97)00087-3","volume":"63","author":"GP Kraan","year":"1997","unstructured":"Kraan GP, Dullaart RP, Pratt JJ, Wolthers BG, de Bruin R (1997) Kinetics of intravenously dosed cortisol in four men. Consequences for calculation of the plasma cortisol production rate. J Steroid Biochem Mol Biol 63:139\u2013146","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jcem.86.6.7522","volume":"86","author":"E Charmandari","year":"2001","unstructured":"Charmandari E, Hindmarsh PC, Johnston A, Brook CG (2001) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab 86:2701\u20132708","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jcem.87.3.8297","volume":"87","author":"M Groschl","year":"2002","unstructured":"Groschl M, Rauh M, Dorr HG (2002) Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 87:1200\u20131204","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2265.1996.d01-1552.x","volume":"45","author":"KA Al-Shoumer","year":"1996","unstructured":"Al-Shoumer KA, Ali K, Anyaoku V, Niththyananthan R, Johnston DG (1996) Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clin Endocrinol (Oxf) 45:171\u2013178","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2265.1997.2101025.x","volume":"47","author":"CJ DeVile","year":"1997","unstructured":"DeVile CJ, Stanhope R (1997) Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol (Oxf) 47:37\u201341","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","volume":"63","author":"A Crown","year":"2005","unstructured":"Crown A, Lightman S (2005) Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 63:483\u2013492","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","volume":"64","author":"W Arlt","year":"2006","unstructured":"Arlt W, Rosenthal C, Hahner S, Allolio B (2006) Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64:384\u2013389","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"1_CR38","first-page":"1","volume":"56","author":"PM Stewart","year":"2001","unstructured":"Stewart PM, Toogood AA, Tomlinson JW (2001) Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Horm Res 56(Suppl 1):1\u20136","journal-title":"Horm Res"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.2003.01894.x","volume":"59","author":"FM Swords","year":"2003","unstructured":"Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP (2003) The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clin Endocrinol (Oxf) 59:613\u2013620","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR40","first-page":"561","volume":"86","author":"KK Miller","year":"2001","unstructured":"Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A (2001) Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 86:561\u2013567","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00365510152379003","volume":"61","author":"JA Beentjes","year":"2001","unstructured":"Beentjes JA, Kerstens MN, Dullaart RP (2001) Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate. Scand J Clin Lab Invest 61:277\u2013286","journal-title":"Scand J Clin Lab Invest"},{"key":"1_CR42","first-page":"1727","volume":"85","author":"AA Toogood","year":"2000","unstructured":"Toogood AA, Taylor NF, Shalet SM, Monson JP (2000) Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J Clin Endocrinol Metab 85:1727\u20131730","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/eje.0.1430769","volume":"143","author":"M Tschop","year":"2000","unstructured":"Tschop M, Lahner H, Feldmeier H, Grasberger H, Morrison KM, Janssen OE et al (2000) Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults. Eur J Endocrinol 143:769\u2013773","journal-title":"Eur J Endocrinol"},{"key":"1_CR44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","volume":"41","author":"JU Weaver","year":"1994","unstructured":"Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR et al (1994) The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol (Oxf) 41:639\u2013648","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2005-1694","volume":"91","author":"SK Paulsen","year":"2006","unstructured":"Paulsen SK, Pedersen SB, Jorgensen JO, Fisker S, Christiansen JS, Flyvbjerg A et al (2006) Growth hormone (GH) substitution in GH-deficient patients inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 91:1093\u20131098","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/er.2004-0025","volume":"26","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Nieman LK (2005) The hypothalamic\u2013pituitary\u2013adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26:775\u2013799","journal-title":"Endocr Rev"},{"key":"1_CR47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2796.1999.00538.x","volume":"246","author":"TG Flemming","year":"1999","unstructured":"Flemming TG, Kristensen LO (1999) Quality of self-care in patients on replacement therapy with hydrocortisone. J Intern Med 246:497\u2013501","journal-title":"J Intern Med"},{"key":"1_CR48","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.160.11.1573","volume":"160","author":"PW Ladenson","year":"2000","unstructured":"Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG et al (2000) American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 160:1573\u20131575","journal-title":"Arch Intern Med"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","volume":"363","author":"CG Roberts","year":"2004","unstructured":"Roberts CG, Ladenson PW (2004) Hypothyroidism. Lancet 363:793\u2013803","journal-title":"Lancet"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)04248-3","volume":"357","author":"CA Wardle","year":"2001","unstructured":"Wardle CA, Fraser WD, Squire CR (2001) Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test. Lancet 357:1013\u20131014","journal-title":"Lancet"},{"key":"1_CR51","first-page":"924","volume":"84","author":"E Ferretti","year":"1999","unstructured":"Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924\u2013929","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/105072502760339406","volume":"12","author":"I Shimon","year":"2002","unstructured":"Shimon I, Cohen O, Lubetsky A, Olchovsky D (2002) Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 12:823\u2013827","journal-title":"Thyroid"},{"key":"1_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1500001","volume":"150","author":"O Alexopoulou","year":"2004","unstructured":"Alexopoulou O, Beguin C, De Nayer P, Maiter D (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150:1\u20138","journal-title":"Eur J Endocrinol"},{"key":"1_CR54","first-page":"53","volume":"61","author":"ML Hartoft-Nielsen","year":"2004","unstructured":"Hartoft-Nielsen ML, Lange M, Rasmussen AK, Scherer S, Zimmermann-Belsing T, Feldt-Rasmussen U (2004) Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm Res 61:53\u201357","journal-title":"Horm Res"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1210\/jc.2003-030943","volume":"88","author":"A Mehta","year":"2003","unstructured":"Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT (2003) Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 88:5696\u20135703","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR56","first-page":"3631","volume":"85","author":"L Persani","year":"2000","unstructured":"Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85:3631\u20133635","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR57","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199902113400603","volume":"340","author":"R Bunevicius","year":"1999","unstructured":"Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340:424\u2013429","journal-title":"N Engl J Med"},{"key":"1_CR58","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2003-030139","volume":"88","author":"AM Sawka","year":"2003","unstructured":"Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT (2003) Does a combination regimen of thyroxine (T4) and 3,5,3\u2032-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4551\u20134555","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR59","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2003-030249","volume":"88","author":"JP Walsh","year":"2003","unstructured":"Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG et al (2003) Combined thyroxine\/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88:4543\u20134550","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR60","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1001\/jama.290.22.2952","volume":"290","author":"PW Clyde","year":"2003","unstructured":"Clyde PW, Harari AE, Getka EJ, Shakir KM (2003) Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290:2952\u20132958","journal-title":"JAMA"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2265.2004.02050.x","volume":"60","author":"W Siegmund","year":"2004","unstructured":"Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T et al (2004) Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 60:750\u2013757","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-142-6-200503150-00007","volume":"142","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J (2005) Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing l-thyroxine plus liothyronine with l-thyroxine alone. Ann Intern Med 142:412\u2013424","journal-title":"Ann Intern Med"},{"key":"1_CR63","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jc.2004-2111","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG et al (2005) Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 90:2666\u20132674","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1_CR64","first-page":"74","volume":"56","author":"WM Wiersinga","year":"2001","unstructured":"Wiersinga WM (2001) Thyroid hormone replacement therapy. Horm Res 56(Suppl 1):74\u201381","journal-title":"Horm Res"},{"key":"1_CR65","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"S Andersen","year":"2002","unstructured":"Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002) Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068\u20131072","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMcp010145","volume":"345","author":"AD Toft","year":"2001","unstructured":"Toft AD (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345:512\u2013516","journal-title":"N Engl J Med"},{"key":"1_CR67","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","volume":"142","author":"J Auer","year":"2001","unstructured":"Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 142:838\u2013842","journal-title":"Am Heart J"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","volume":"358","author":"JV Parle","year":"2001","unstructured":"Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861\u2013865","journal-title":"Lancet"},{"key":"1_CR69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","volume":"345","author":"DS Cooper","year":"2001","unstructured":"Cooper DS (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345:260\u2013265","journal-title":"N Engl J Med"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/jcem.86.6.7577","volume":"86","author":"RC Smallridge","year":"2001","unstructured":"Smallridge RC, Ladenson PW (2001) Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab 86:2349\u20132353","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1056\/NEJM200106073442302","volume":"344","author":"BM Arafah","year":"2001","unstructured":"Arafah BM (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344:1743\u20131749","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"1_CR72","first-page":"121","volume":"51","author":"JO Jorgensen","year":"1999","unstructured":"Jorgensen JO, Ovesen P, Juul A, Hansen TK, Skakkebaek NE, Christiansen JS (1999) Impact of growth hormone administration on other hormonal axes. Horm Res 51(Suppl 3):121\u2013126","journal-title":"Horm Res"},{"key":"1_CR73","doi-asserted-by":"crossref","unstructured":"Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society (2001) J Clin Endocrinol Metab 86:1868\u20131870","DOI":"10.1210\/jc.86.5.1868"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","volume":"87","author":"S Porretti","year":"2002","unstructured":"Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D et al (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 87:2042\u20132045","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR75","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995\u20132010","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmh035","volume":"10","author":"E Nieschlag","year":"2004","unstructured":"Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK et al (2004) Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 10:409\u2013419","journal-title":"Hum Reprod Update"},{"key":"1_CR77","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/13685530400016615","volume":"7","author":"A Vermeulen","year":"2004","unstructured":"Vermeulen A (2004) Reflections concerning biochemical parameters of androgenicity. Aging Male 7:280\u2013289","journal-title":"Aging Male"},{"key":"1_CR78","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","volume":"26","author":"JM Kaufman","year":"2005","unstructured":"Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833\u2013876","journal-title":"Endocr Rev"},{"key":"1_CR79","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666\u20133672","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1_CR80","first-page":"86","volume":"56","author":"S Howell","year":"2001","unstructured":"Howell S, Shalet S (2001) Testosterone deficiency and replacement. Horm Res 56(Suppl 1):86\u201392","journal-title":"Horm Res"},{"key":"1_CR81","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.2003-031802","volume":"89","author":"C Wang","year":"2004","unstructured":"Wang C, Catlin DH, Starcevic B, Leung A, DiStefano E, Lucas G et al (2004) Testosterone metabolic clearance and production rates determined by stable isotope dilution\/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab 89:2936\u20132941","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/meta.2003.50028","volume":"52","author":"H Vierhapper","year":"2003","unstructured":"Vierhapper H, Nowotny P, Waldhausl W (2003) Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone. Metabolism 52:230\u2013232","journal-title":"Metabolism"},{"key":"1_CR83","first-page":"3735","volume":"83","author":"H Vierhapper","year":"1998","unstructured":"Vierhapper H, Nowotny P, Waldhausl W (1998) Unchanged testosterone production rates in growth hormone-treated healthy men. J Clin Endocrinol Metab 83:3735\u20133736","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR84","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/tam.5.2.74.86","volume":"5","author":"A Morales","year":"2002","unstructured":"Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 5:74\u201386","journal-title":"Aging Male"},{"key":"1_CR85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2605.2005.00553.x","volume":"28","author":"E Nieschlag","year":"2005","unstructured":"Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ et al (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28:125\u2013127","journal-title":"Int J Androl"},{"key":"1_CR86","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","volume":"350","author":"EL Rhoden","year":"2004","unstructured":"Rhoden EL, Morgentaler A (2004) Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482\u2013492","journal-title":"N Engl J Med"},{"key":"1_CR87","doi-asserted-by":"crossref","unstructured":"National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms (2005) Ann Intern Med 142:1003\u20131013","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00117"},{"key":"1_CR88","doi-asserted-by":"crossref","unstructured":"Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force (2005) Ann Intern Med 142:855\u2013860","DOI":"10.7326\/0003-4819-142-10-200505170-00011"},{"key":"1_CR89","doi-asserted-by":"crossref","unstructured":"Farquhar CM, Marjoribanks J, Lethaby A, Lamberts Q, Suckling JA. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2005:CD004143","DOI":"10.1002\/14651858.CD004143.pub2"},{"key":"1_CR90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","volume":"366","author":"M Hickey","year":"2005","unstructured":"Hickey M, Davis SR, Sturdee DW (2005) Treatment of menopausal symptoms: what shall we do now? Lancet 366:409\u2013421","journal-title":"Lancet"},{"key":"1_CR91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2005.02.019","volume":"51","author":"SO Skouby","year":"2005","unstructured":"Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertungealp J, Gompel A, Graziottin A et al (2005) Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004\/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas 51:8\u201314","journal-title":"Maturitas"},{"key":"1_CR92","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425\u2013431","journal-title":"Lancet"},{"key":"1_CR93","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1210\/jc.2005-1207","volume":"90","author":"PM Mah","year":"2005","unstructured":"Mah PM, Webster J, Jonsson P, Feldt-Rasmussen U, Koltowska-Haggstrom M, Ross RJ (2005) Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab 90:5964\u20135969","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00024677-200605010-00005","volume":"5","author":"DV Menon","year":"2006","unstructured":"Menon DV, Vongpatanasin W (2006) Effects of transdermal estrogen replacement therapy on cardiovascular risk factors. Treat Endocrinol 5:37\u201351","journal-title":"Treat Endocrinol"},{"key":"1_CR95","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25:693\u2013721","journal-title":"Endocr Rev"},{"key":"1_CR96","doi-asserted-by":"crossref","unstructured":"Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2000:CD000402","DOI":"10.1002\/14651858.CD000402"},{"key":"1_CR97","first-page":"625","volume":"51","author":"MW Elmlinger","year":"2005","unstructured":"Elmlinger MW, Kuhnel W, Wormstall H, Doller PC (2005) Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab 51:625\u2013632","journal-title":"Clin Lab"},{"key":"1_CR98","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0015-0282(02)02969-2","volume":"77","author":"G Bachmann","year":"2002","unstructured":"Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L et al (2002) Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77:660\u2013665","journal-title":"Fertil Steril"},{"key":"1_CR99","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1210\/jc.2004-2063","volume":"90","author":"N Santoro","year":"2005","unstructured":"Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB et al (2005) Correlates of circulating androgens in mid-life women: the study of women\u2019s health across the nation. J Clin Endocrinol Metab 90:4836\u20134845","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR100","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jc.2005-1328","volume":"90","author":"S Bhasin","year":"2005","unstructured":"Bhasin S (2005) Female androgen deficiency syndrome\u2014an unproven hypothesis. J Clin Endocrinol Metab 90:4970\u20134972","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR101","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMcp050154","volume":"354","author":"R Basson","year":"2006","unstructured":"Basson R (2006) Clinical practice. Sexual desire and arousal disorders in women. N Engl J Med 354:1497\u20131506","journal-title":"N Engl J Med"},{"key":"1_CR102","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","volume":"341","author":"W Arlt","year":"1999","unstructured":"Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M et al (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013\u20131020","journal-title":"N Engl J Med"},{"key":"1_CR103","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2265.2000.01017.x","volume":"52","author":"G Gebre-Medhin","year":"2000","unstructured":"Gebre-Medhin G, Husebye ES, Mallmin H, Helstrom L, Berne C, Karlsson FA et al (2000) Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison\u2019s disease. Clin Endocrinol (Oxf) 52:775\u2013780","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR104","first-page":"4650","volume":"85","author":"PJ Hunt","year":"2000","unstructured":"Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA et al (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650\u20134656","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/eje.0.1450103","volume":"145","author":"EM Gurnell","year":"2001","unstructured":"Gurnell EM, Chatterjee VK (2001) Dehydroepiandrosterone replacement therapy. Eur J Endocrinol 145:103\u2013106","journal-title":"Eur J Endocrinol"},{"key":"1_CR106","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jcem.87.5.8494","volume":"87","author":"G Johannsson","year":"2002","unstructured":"Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M et al (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046\u20132052","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"1_CR107","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.280.18.1565","volume":"280","author":"J Parasrampuria","year":"1998","unstructured":"Parasrampuria J, Schwartz K, Petesch R (1998) Quality control of dehydroepiandrosterone dietary supplement products. JAMA 280(18):1565","journal-title":"JAMA"},{"key":"1_CR108","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","volume":"105","author":"JE Buster","year":"2005","unstructured":"Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A et al (2005) Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105:944\u2013952","journal-title":"Obstet Gynecol"},{"key":"1_CR109","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","volume":"165","author":"GD Braunstein","year":"2005","unstructured":"Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA et al (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165:1582\u20131589","journal-title":"Arch Intern Med"},{"key":"1_CR110","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","volume":"90","author":"J Simon","year":"2005","unstructured":"Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S et al (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90:5226\u20135233","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","volume":"13","author":"SR Davis","year":"2006","unstructured":"Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot J, Rees M et al (2006) Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 13:387\u2013396","journal-title":"Menopause"},{"key":"1_CR112","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2005-2596","volume":"91","author":"KK Miller","year":"2006","unstructured":"Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D et al (2006) Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 91:1683\u20131690","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1_CR113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.ijir.3901481","volume":"19","author":"D Shames","year":"2007","unstructured":"Shames D, Monroe SE, Davis D, Soule L (2007) Regulatory perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an environment of evolving clinical science. Int J Impot Res 19(1):30\u201336","journal-title":"Int J Impot Res"},{"key":"1_CR114","doi-asserted-by":"crossref","unstructured":"The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society (2005) Menopause 12:496\u2013511; quiz 649","DOI":"10.1097\/01.gme.0000177709.65944.b0"},{"key":"1_CR115","doi-asserted-by":"crossref","unstructured":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency (1998) J Clin Endocrinol Metab 83:379\u2013381","DOI":"10.1210\/jc.83.2.379"},{"key":"1_CR116","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4158\/EP.9.1.64","volume":"9","author":"H Gharib","year":"2003","unstructured":"Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB et al (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children\u20142003 update. Endocr Pract 9:64\u201376","journal-title":"Endocr Pract"},{"key":"1_CR117","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/jc.2005-2227","volume":"91","author":"ME Molitch","year":"2006","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML et al (2006) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:1621\u20131634","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR118","doi-asserted-by":"crossref","unstructured":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society (2000) J Clin Endocrinol Metab 85:3990\u20133993","DOI":"10.1210\/jc.85.11.3990"},{"key":"1_CR119","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","volume":"143","author":"TA Wilson","year":"2003","unstructured":"Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R et al (2003) Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 143:415\u2013421","journal-title":"J Pediatr"},{"key":"1_CR120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 152:165\u2013170","journal-title":"Eur J Endocrinol"},{"key":"1_CR121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/er.2005-0006","volume":"27","author":"JD Veldhuis","year":"2006","unstructured":"Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY (2006) Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty\u2013adult transition. Endocr Rev 27:101\u2013140","journal-title":"Endocr Rev"},{"key":"1_CR122","first-page":"1615","volume":"83","author":"G Aimaretti","year":"1998","unstructured":"Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E et al (1998) Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone\u00a0+\u00a0arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615\u20131618","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR123","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","volume":"87","author":"BM Biller","year":"2002","unstructured":"Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V et al (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067\u20132079","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1_CR124","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1530\/eje.0.148S003","volume":"148","author":"R Abs","year":"2003","unstructured":"Abs R (2003) Update on the diagnosis of GH deficiency in adults. Eur J Endocrinol 148(Suppl 2):S3\u2013S8","journal-title":"Eur J Endocrinol"},{"key":"1_CR125","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1210\/jc.2003-032213","volume":"89","author":"VS Bonert","year":"2004","unstructured":"Bonert VS, Elashoff JD, Barnett P, Melmed S (2004) Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab 89:3397\u20133401","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR126","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2004-1450","volume":"90","author":"XD Qu","year":"2005","unstructured":"Qu XD, Gaw Gonzalo IT, Al Sayed MY, Cohan P, Christenson PD, Swerdloff RS et al (2005) Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab 90:1563\u20131569","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR127","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","volume":"153","author":"G Corneli","year":"2005","unstructured":"Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG et al (2005) The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257\u2013264","journal-title":"Eur J Endocrinol"},{"key":"1_CR128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2265.2003.01794.x","volume":"59","author":"G Aimaretti","year":"2003","unstructured":"Aimaretti G, Corneli G, Baldelli R, Di Somma C, Gasco V, Durante C et al (2003) Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clin Endocrinol (Oxf) 59:56\u201361","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87:477\u2013485","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/er.2004-0022","volume":"27","author":"LJ Woodhouse","year":"2006","unstructured":"Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S (2006) The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 27:287\u2013317","journal-title":"Endocr Rev"},{"key":"1_CR131","first-page":"53","volume":"60","author":"G Brabant","year":"2003","unstructured":"Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W et al (2003) Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53\u201360","journal-title":"Horm Res"},{"key":"1_CR132","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.2005.02271.x","volume":"62","author":"A Jostel","year":"2005","unstructured":"Jostel A, Mukherjee A, Alenfall J, Smethurst L, Shalet SM (2005) A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile. Clin Endocrinol (Oxf) 62:623\u2013627","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR133","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1210\/jc.2005-0928","volume":"90","author":"AR Hoffman","year":"2005","unstructured":"Hoffman AR, Biller BM, Cook D, Baptista J, Silverman BL, Dao L et al (2005) Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab 90:6431\u20136440","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR134","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1210\/jcem.87.5.8454","volume":"87","author":"A Kehely","year":"2002","unstructured":"Kehely A, Bates PC, Frewer P, Birkett M, Blum WF, Mamessier P et al (2002) Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms. J Clin Endocrinol Metab 87:1974\u20131979","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR135","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2003-032082","volume":"89","author":"AR Hoffman","year":"2004","unstructured":"Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML (2004) Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab 89:3224\u20133233","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR136","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","volume":"84","author":"BA Bengtsson","year":"1999","unstructured":"Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E et al (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J Clin Endocrinol Metab 84:3929\u20133935","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR137","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","volume":"86","author":"G Gotherstrom","year":"2001","unstructured":"Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B et al (2001) A prospective study of 5\u00a0years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86:4657\u20134665","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR138","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.2000.00971.x","volume":"52","author":"RD Murray","year":"2000","unstructured":"Murray RD, Howell SJ, Lissett CA, Shalet SM (2000) Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency. Clin Endocrinol (Oxf) 52:537\u2013542","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR139","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","volume":"50","author":"R Abs","year":"1999","unstructured":"Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P et al (1999) GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf) 50:703\u2013713","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR140","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","volume":"88","author":"LE Underwood","year":"2003","unstructured":"Underwood LE, Attie KM, Baptista J (2003) Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. J Clin Endocrinol Metab 88:5273\u20135280","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"1_CR141","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ghir.2004.03.013","volume":"14","author":"U Feldt-Rasmussen","year":"2004","unstructured":"Feldt-Rasmussen U, Wilton P, Jonsson P (2004) Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Horm IGF Res 14(Suppl A):S51\u201358","journal-title":"Growth Horm IGF Res"},{"key":"1_CR142","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","volume":"83","author":"PV Carroll","year":"1998","unstructured":"Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D et al (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382\u2013395","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR143","first-page":"1600","volume":"87","author":"AF Attanasio","year":"2002","unstructured":"Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ et al (2002) Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status\u20143-year results from the HypoCCS Database. J Clin Endocrinol Metab 87:1600\u20131606","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR144","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","volume":"89","author":"P Maison","year":"2004","unstructured":"Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192\u20132199","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR145","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2002-020901","volume":"88","author":"J Svensson","year":"2003","unstructured":"Svensson J, Stibrant Sunnerhagen K, Johannsson G (2003) Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. J Clin Endocrinol Metab 88:2061\u20132069","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR146","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","volume":"84","author":"J Gibney","year":"1999","unstructured":"Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC et al (1999) The effects of 10\u00a0years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metab 84:2596\u20132602","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR147","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.2004.02181.x","volume":"62","author":"G Gotherstrom","year":"2005","unstructured":"Gotherstrom G, Bengtsson BA, Sunnerhagen KS, Johannsson G, Svensson J (2005) The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Clin Endocrinol (Oxf) 62:105\u2013113","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR148","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/01.CIR.0000100720.01867.1D","volume":"108","author":"P Maison","year":"2003","unstructured":"Maison P, Chanson P (2003) Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 108:2648\u20132652","journal-title":"Circulation"},{"key":"1_CR149","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/edrv.22.4.0438","volume":"22","author":"WM Drake","year":"2001","unstructured":"Drake WM, Howell SJ, Monson JP, Shalet SM (2001) Optimizing gh therapy in adults and children. Endocr Rev 22:425\u2013450","journal-title":"Endocr Rev"},{"key":"1_CR150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","volume":"16","author":"C Wuster","year":"2001","unstructured":"Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E et al (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398\u2013405","journal-title":"J Bone Miner Res"},{"key":"1_CR151","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2004.01935.x","volume":"60","author":"P Davidson","year":"2004","unstructured":"Davidson P, Milne R, Chase D, Cooper C (2004) Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 60:92\u201398","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR152","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/JBMR.050613","volume":"20","author":"N Bravenboer","year":"2005","unstructured":"Bravenboer N, Holzmann PJ, ter Maaten JC, Stuurman LM, Roos JC, Lips P (2005) Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men. J Bone Miner Res 20:1778\u20131784","journal-title":"J Bone Miner Res"},{"key":"1_CR153","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2005.02343.x","volume":"63","author":"LI Arwert","year":"2005","unstructured":"Arwert LI, Roos JC, Lips P, Twisk JW, Manoliu RA, Drent ML (2005) Effects of 10\u00a0years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clin Endocrinol (Oxf) 63:310\u2013316","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR154","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1210\/jcem.86.11.7997","volume":"86","author":"E Hernberg-Stahl","year":"2001","unstructured":"Hernberg-Stahl E, Luger A, Abs R, Bengtsson BA, Feldt-Rasmussen U, Wilton P et al (2001) Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab 86:5277\u20135281","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00019053-200422080-00003","volume":"22","author":"DJ Radcliffe","year":"2004","unstructured":"Radcliffe DJ, Pliskin JS, Silvers JB, Cuttler L (2004) Growth hormone therapy and quality of life in adults and children. Pharmacoeconomics 22:499\u2013524","journal-title":"Pharmacoeconomics"},{"key":"1_CR156","first-page":"46","volume":"64","author":"M Koltowska-Haggstrom","year":"2005","unstructured":"Koltowska-Haggstrom M, Hennessy S, Mattsson AF, Monson JP, Kind P (2005) Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Horm Res 64:46\u201354","journal-title":"Horm Res"},{"key":"1_CR157","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","volume":"89","author":"M Rosilio","year":"2004","unstructured":"Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW et al (2004) Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab 89:1684\u20131693","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR158","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2002-021792","volume":"88","author":"WF Blum","year":"2003","unstructured":"Blum WF, Shavrikova EP, Edwards DJ, Rosilio M, Hartman ML, Marin F et al (2003) Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module. J Clin Endocrinol Metab 88:4158\u20134167","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"1_CR159","first-page":"42","volume":"62","author":"A Colao","year":"2004","unstructured":"Colao A (2004) Cardiovascular effects of growth hormone treatment: potential risks and benefits. Horm Res 62(Suppl 3):42\u201350","journal-title":"Horm Res"},{"key":"1_CR160","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1210\/jc.2004-2247","volume":"90","author":"A Colao","year":"2005","unstructured":"Colao A, Di Somma C, Rota F, Pivonello R, Savanelli MC, Spiezia S et al (2005) Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab 90:2056\u20132062","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR161","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1210\/jc.2004-1042","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W et al (2004) The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 89:5998\u20136004","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR162","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1210\/jc.2004-0545","volume":"90","author":"M Gola","year":"2005","unstructured":"Gola M, Bonadonna S, Doga M, Giustina A (2005) Clinical review: growth hormone and cardiovascular risk factors. J Clin Endocrinol Metab 90:1864\u20131870","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR163","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1210\/jc.2005-0091","volume":"90","author":"R Lanes","year":"2005","unstructured":"Lanes R, Soros A, Flores K, Gunczler P, Carrillo E, Bandel J (2005) Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 90:3978\u20133982","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR164","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1517\/14740338.4.6.1069","volume":"4","author":"A Toogood","year":"2005","unstructured":"Toogood A (2005) Safety and efficacy of growth hormone replacement therapy in adults. Expert Opin Drug Saf 4:1069\u20131082","journal-title":"Expert Opin Drug Saf"},{"key":"1_CR165","first-page":"209","volume":"33","author":"M Waterhouse","year":"2005","unstructured":"Waterhouse M, Monson JP (2005) Safety aspects of growth hormone replacement. Front Horm Res 33:209\u2013221","journal-title":"Front Horm Res"},{"key":"1_CR166","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00002018-200225030-00005","volume":"25","author":"W Jeffcoate","year":"2002","unstructured":"Jeffcoate W (2002) Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Saf 25:199\u2013212","journal-title":"Drug Saf"},{"key":"1_CR167","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(05)73137-8","volume":"355","author":"JP Monson","year":"2000","unstructured":"Monson JP, Bengtsson BA, Abs R, Feldt-Rasmussen U, Wuster C (2000) Can growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet 355:1728\u20131729","journal-title":"Lancet"},{"key":"1_CR168","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02359.x","volume":"63","author":"KC Yuen","year":"2005","unstructured":"Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE et al (2005) Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clin Endocrinol (Oxf) 63:428\u2013436","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR169","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1210\/jcem.86.11.8018","volume":"86","author":"G Frajese","year":"2001","unstructured":"Frajese G, Drake WM, Loureiro RA, Evanson J, Coyte D, Wood DF et al (2001) Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy. J Clin Endocrinol Metab 86:5172\u20135175","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","volume":"63","author":"TT Chung","year":"2005","unstructured":"Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL et al (2005) Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin Endocrinol (Oxf) 63:274\u2013279","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-007-0001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-007-0001-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-007-0001-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T14:33:35Z","timestamp":1707575615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-007-0001-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,31]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4,4]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11102-007-0001-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,31]]}}}